MKI67 and invasive breast carcinoma: The present study aimed to compare the 2D ROI-ADC measurement with the Ki-67 proliferation index before and after NACT to assess ADC changes as a predictive biomarker for changes in the Ki-67 index due to NACT in patients with invasive breast cancer.